Complement Factor H and Apolipoprotein E Participate in Regulation of Inflammation in THP-1 Macrophages

Autor: Karita Haapasalo, Shahan Syed, Seppo Meri, Katarzyna Leskinen, Pipsa Hakala, Angeliki Chroni, T. Sakari Jokiranta, Carla J. C. de Haas, Angela Roig, Matti Jauhiainen, Päivi Saavalainen, Jari Metso, Eija Nissilä, Katariina Öörni, Kok P. M. van Kessel, Jos A. G. van Strijp
Přispěvatelé: Immunobiology Research Program, Department of Bacteriology and Immunology, Medicum, Research Programs Unit, University of Helsinki, Immunomics, Seppo Meri / Principal Investigator
Jazyk: angličtina
Rok vydání: 2018
Předmět:
0301 basic medicine
Apolipoprotein E
Transcription
Genetic

THP-1 Cells
Monocytes
ACTIVATION
0302 clinical medicine
Immunology and Allergy
complement
Original Research
apolipoprotein E
DENSE DEPOSIT DISEASE
Chemistry
Cell biology
A-I
medicine.anatomical_structure
Complement Factor H
030220 oncology & carcinogenesis
Factor H
Complement C3b
E SECRETION
lipids (amino acids
peptides
and proteins)

medicine.symptom
Lipoproteins
HDL

HUMAN SERUM
lcsh:Immunologic diseases. Allergy
Immunology
Inflammation
Proinflammatory cytokine
03 medical and health sciences
Apolipoproteins E
medicine
Humans
complement system
Monocyte
MACULAR DEGENERATION
Complement system
030104 developmental biology
MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS
inflammation
CELLS
Alternative complement pathway
iC3b
HEMOLYTIC-UREMIC SYNDROME
3111 Biomedicine
atherosclerosis
lcsh:RC581-607
Foam Cells
PROTEIN BETA-1H
Zdroj: Frontiers in Immunology, Vol 9 (2018)
Frontiers in Immunology
Popis: The alternative pathway (AP) of complement is constantly active in plasma and can easily be activated on self surfaces and trigger local inflammation. Host cells are protected from AP attack by Factor H (FH), the main AP regulator in plasma. Although complement is known to play a role in atherosclerosis, the mechanisms of its contribution are not fully understood. Since FH via its domains 5-7 binds apoliporotein E (apoE) and macrophages produce apoE we examined how FH could be involved in the antiatherogenic effects of apoE. We used blood peripheral monocytes and THP-1 monocyte/macrophage cells which were also loaded with acetylated low-density lipoprotein (LDL) to form foam cells. Binding of FH and apoE on these cells was analyzed by flow cytometry. High-density lipoprotein (HDL)-mediated cholesterol efflux of activated THP-1 cells was measured and transcriptomes of THP-1 cells using mRNA sequencing were determined. We found that binding of FH to human blood monocytes and cholesterol-loaded THP-1 macrophages increased apoE binding to these cells. Preincubation of fluorescent cholesterol labeled THP-1 macrophages in the presence of FH increased cholesterol efflux and cholesterol-loaded macrophages displayed reduced transcription of proinflammatory/proatherogenic factors and increased transcription of anti-inflammatory/anti-atherogenic factors. Further incubation of THP-1 cells with serum reduced C3b/iC3b deposition. Overall, our data indicate that apoE and FH interact with monocytic cells in a concerted action and this interaction reduces complement activation and inflammation in the atherosclerotic lesions. By this way FH may participate in mediating the beneficial effects of apoE in suppressing atherosclerotic lesion progression.
Databáze: OpenAIRE